Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort Study
{{output}}
Background: Patients with acute myeloid leukemia (AML) treated with hypomethylating agents and venetoclax (HMA-VEN) may be at risk for cardiovascular complications. The incidence, associations, and prognostic implications of thes... ...
